angiotensin ii has been researched along with daidzein in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chrissobolis, S; Jackman, KA; Sobey, CG; Woodman, OL | 1 |
He, W; Liu, JX; Xiong, XQ; Zhou, L; Zhou, Q | 1 |
Bai, YQ; Liu, YF; Qi, M | 1 |
3 other study(ies) available for angiotensin ii and daidzein
Article | Year |
---|---|
Vasorelaxant and antioxidant activity of the isoflavone metabolite equol in carotid and cerebral arteries.
Topics: Analysis of Variance; Angiotensin II; Animals; Antioxidants; Blood Pressure; Carotid Arteries; Cerebral Arteries; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Equol; Female; Hypertension; In Vitro Techniques; Isoflavones; Male; Phytoestrogens; Rats; Superoxides; Vasodilation | 2007 |
[Influence of daidzein on left ventricular remodeling in rats with hypertrophic myocardium induced by pressure overload].
Topics: Angiotensin II; Animals; Hypertrophy, Left Ventricular; Isoflavones; Male; Myocardium; Nitric Oxide; Phytoestrogens; Random Allocation; Rats; Rats, Wistar; Ventricular Remodeling | 2007 |
Daidzein attenuates abdominal aortic aneurysm through NF-κB, p38MAPK and TGF-β1 pathways.
Topics: Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Disease Models, Animal; Gene Expression; Isoflavones; Male; Matrix Metalloproteinase 2; Mice; NF-kappa B; Nitric Oxide Synthase Type II; p38 Mitogen-Activated Protein Kinases; Signal Transduction; Tissue Inhibitor of Metalloproteinase-1; Transforming Growth Factor beta1 | 2016 |